{"entity":{"type":"insider","cik":"0001423084","url":"/insider/0001423084","json_url":"/insider/0001423084.json","name":"Schall Thomas J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":104,"n_filings":46,"first":"2012-10-03","last":"2026-01-20","span_basis":"filed_date"},"name_variants":[{"name":"Schall Thomas J.","source":"filing","n_filings":46,"first_seen":"2012-10-03","last_seen":"2026-01-20"}],"transactions":[{"id":5969804,"accession":"0001790340-26-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001790340-26-000014","line_url":"/filing/0001790340-26-000014#line-1","is_derivative":false,"issuer_cik":"0001423084","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001423084","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21645.0,"shares_display":"21,645","price_per_share":4.6681,"price_display":"4.67","price_state":"stated","total_value":101041.0245,"total_display":"101,041.02","total_whole":"101,041","shares_owned_after":74530.0,"shares_owned_after_display":"74,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider"},{"id":4037922,"accession":"0001790340-25-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001790340-25-000089","line_url":"/filing/0001790340-25-000089#line-1","is_derivative":false,"issuer_cik":"0001423084","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001423084","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":3.6619,"price_display":"3.66","price_state":"stated","total_value":34788.05,"total_display":"34,788.05","total_whole":"34,788","shares_owned_after":52885.0,"shares_owned_after_display":"52,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-06-30","scope":"insider"},{"id":4037920,"accession":"0001790340-25-000079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001790340-25-000079","line_url":"/filing/0001790340-25-000079#line-1","is_derivative":false,"issuer_cik":"0001423084","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001423084","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40485.0,"shares_display":"40,485","price_per_share":2.2052,"price_display":"2.21","price_state":"stated","total_value":89277.522,"total_display":"89,277.52","total_whole":"89,278","shares_owned_after":43385.0,"shares_owned_after_display":"43,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-18","scope":"insider"},{"id":2329365,"accession":"0001415889-24-009028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009028","line_url":"/filing/0001415889-24-009028#line-1","is_derivative":false,"issuer_cik":"0001423084","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001423084","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2900.0,"shares_display":"2,900","price_per_share":2.5465,"price_display":"2.55","price_state":"stated","total_value":7384.85,"total_display":"7,384.85","total_whole":"7,385","shares_owned_after":2900.0,"shares_owned_after_display":"2,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-22","filed_date":"2024-03-25","scope":"insider"},{"id":6893084,"accession":"0001209191-22-044896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-044896","line_url":"/filing/0001209191-22-044896#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130000.0,"shares_display":"130,000","price_per_share":50.2441,"price_display":"50.24","price_state":"stated","total_value":6531733.0,"total_display":"6,531,733.00","total_whole":"6,531,733","shares_owned_after":2393352.0,"shares_owned_after_display":"2,393,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-08","scope":"insider"},{"id":2691855,"accession":"0001209191-20-063919","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-063919","line_url":"/filing/0001209191-20-063919#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17619.0,"shares_display":"17,619","price_per_share":65.0122,"price_display":"65.01","price_state":"stated","total_value":1145449.9518,"total_display":"1,145,449.95","total_whole":"1,145,450","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider"},{"id":2691844,"accession":"0001209191-20-063919","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-063919","line_url":"/filing/0001209191-20-063919#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11153.0,"shares_display":"11,153","price_per_share":65.027,"price_display":"65.03","price_state":"stated","total_value":725246.131,"total_display":"725,246.13","total_whole":"725,246","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":2470776,"accession":"0001209191-20-037135","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-037135","line_url":"/filing/0001209191-20-037135#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":65.0448,"price_display":"65.04","price_state":"stated","total_value":130089.6,"total_display":"130,089.60","total_whole":"130,090","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-16","scope":"insider"},{"id":2470760,"accession":"0001209191-20-037135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037135","line_url":"/filing/0001209191-20-037135#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88753.0,"shares_display":"88,753","price_per_share":65.0781,"price_display":"65.08","price_state":"stated","total_value":5775876.6093,"total_display":"5,775,876.61","total_whole":"5,775,877","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-16","scope":"insider"},{"id":2286286,"accession":"0001209191-20-028669","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-028669","line_url":"/filing/0001209191-20-028669#line-7","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35865.0,"shares_display":"35,865","price_per_share":57.7471,"price_display":"57.75","price_state":"stated","total_value":2071099.7415,"total_display":"2,071,099.74","total_whole":"2,071,100","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-12","scope":"insider"},{"id":2286279,"accession":"0001209191-20-028669","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-028669","line_url":"/filing/0001209191-20-028669","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70608.0,"shares_display":"70,608","price_per_share":55.513972093813734,"price_display":"55.51","price_state":"stated","total_value":3919730.5416,"total_display":"3,919,730.54","total_whole":"3,919,731","shares_owned_after":2284586.0,"shares_owned_after_display":"2,284,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-12","scope":"insider","n_lines":2},{"id":2286264,"accession":"0001209191-20-028669","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-028669","line_url":"/filing/0001209191-20-028669#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4201.0,"shares_display":"4,201","price_per_share":55.0142,"price_display":"55.01","price_state":"stated","total_value":231114.6542,"total_display":"231,114.65","total_whole":"231,115","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-12","scope":"insider"},{"id":3197398,"accession":"0001209191-20-027817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-027817","line_url":"/filing/0001209191-20-027817#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8851.0,"shares_display":"8,851","price_per_share":55.0052,"price_display":"55.01","price_state":"stated","total_value":486851.0252,"total_display":"486,851.03","total_whole":"486,851","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider"},{"id":2178087,"accession":"0001209191-20-016765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016765","line_url":"/filing/0001209191-20-016765#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40844.0,"shares_display":"40,844","price_per_share":50.3548,"price_display":"50.35","price_state":"stated","total_value":2056691.4512,"total_display":"2,056,691.45","total_whole":"2,056,691","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-04","filed_date":"2020-03-05","scope":"insider"},{"id":2895836,"accession":"0001209191-20-011796","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-011796","line_url":"/filing/0001209191-20-011796","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15341.0,"shares_display":"15,341","price_per_share":50.21158260869565,"price_display":"50.21","price_state":"stated","total_value":770295.8888,"total_display":"770,295.89","total_whole":"770,296","shares_owned_after":2268586.0,"shares_owned_after_display":"2,268,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-20","filed_date":"2020-02-21","scope":"insider","n_lines":2},{"id":2895827,"accession":"0001209191-20-011796","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-011796","line_url":"/filing/0001209191-20-011796","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63340.0,"shares_display":"63,340","price_per_share":50.497530206820336,"price_display":"50.50","price_state":"stated","total_value":3198513.5633,"total_display":"3,198,513.56","total_whole":"3,198,514","shares_owned_after":2276280.0,"shares_owned_after_display":"2,276,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-21","scope":"insider","n_lines":2},{"id":3188213,"accession":"0001209191-20-007294","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-007294","line_url":"/filing/0001209191-20-007294#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119525.0,"shares_display":"119,525","price_per_share":45.1847,"price_display":"45.18","price_state":"stated","total_value":5400701.2675,"total_display":"5,400,701.27","total_whole":"5,400,701","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider"},{"id":2433011,"accession":"0001209191-20-004185","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-004185","line_url":"/filing/0001209191-20-004185","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105735.0,"shares_display":"105,735","price_per_share":41.5971203603348,"price_display":"41.60","price_state":"stated","total_value":4398271.5213,"total_display":"4,398,271.52","total_whole":"4,398,272","shares_owned_after":2290736.0,"shares_owned_after_display":"2,290,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-17","filed_date":"2020-01-17","scope":"insider","n_lines":2},{"id":2432998,"accession":"0001209191-20-004185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-004185","line_url":"/filing/0001209191-20-004185#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30317.0,"shares_display":"30,317","price_per_share":41.0057,"price_display":"41.01","price_state":"stated","total_value":1243169.8069,"total_display":"1,243,169.81","total_whole":"1,243,170","shares_owned_after":2268557.0,"shares_owned_after_display":"2,268,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-16","filed_date":"2020-01-17","scope":"insider"},{"id":8455228,"accession":"0001209191-19-058382","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-19-058382","line_url":"/filing/0001209191-19-058382","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":279166.0,"shares_display":"279,166","price_per_share":31.55152306298045,"price_display":"31.55","price_state":"stated","total_value":8808112.4874,"total_display":"8,808,112.49","total_whole":"8,808,112","shares_owned_after":2362330.0,"shares_owned_after_display":"2,362,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-27","scope":"insider","n_lines":9},{"id":8296621,"accession":"0001209191-19-022818","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-022818","line_url":"/filing/0001209191-19-022818#line-6","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74986.0,"shares_display":"74,986","price_per_share":13.8547,"price_display":"13.85","price_state":"stated","total_value":1038908.5342,"total_display":"1,038,908.53","total_whole":"1,038,909","shares_owned_after":2228855.0,"shares_owned_after_display":"2,228,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-02","filed_date":"2019-04-02","scope":"insider"},{"id":8296614,"accession":"0001209191-19-022818","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-022818","line_url":"/filing/0001209191-19-022818#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79259.0,"shares_display":"79,259","price_per_share":13.5768,"price_display":"13.58","price_state":"stated","total_value":1076083.5912,"total_display":"1,076,083.59","total_whole":"1,076,084","shares_owned_after":2228855.0,"shares_owned_after_display":"2,228,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-01","filed_date":"2019-04-02","scope":"insider"},{"id":8296608,"accession":"0001209191-19-022818","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-022818","line_url":"/filing/0001209191-19-022818#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5755.0,"shares_display":"5,755","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":80570.0,"total_display":"80,570.00","total_whole":"80,570","shares_owned_after":2228855.0,"shares_owned_after_display":"2,228,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-29","filed_date":"2019-04-02","scope":"insider"},{"id":8525982,"accession":"0001209191-19-003643","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003643","line_url":"/filing/0001209191-19-003643#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36762.0,"shares_display":"36,762","price_per_share":12.1618,"price_display":"12.16","price_state":"stated","total_value":447092.0916,"total_display":"447,092.09","total_whole":"447,092","shares_owned_after":2228855.0,"shares_owned_after_display":"2,228,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-10","filed_date":"2019-01-14","scope":"insider"},{"id":7787318,"accession":"0001209191-19-003169","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-003169","line_url":"/filing/0001209191-19-003169#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12895.0,"shares_display":"12,895","price_per_share":12.0024,"price_display":"12.00","price_state":"stated","total_value":154770.948,"total_display":"154,770.95","total_whole":"154,771","shares_owned_after":2228855.0,"shares_owned_after_display":"2,228,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-09","filed_date":"2019-01-09","scope":"insider"},{"id":7787315,"accession":"0001209191-19-003169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003169","line_url":"/filing/0001209191-19-003169#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7275.0,"shares_display":"7,275","price_per_share":12.0411,"price_display":"12.04","price_state":"stated","total_value":87599.0025,"total_display":"87,599.00","total_whole":"87,599","shares_owned_after":2228855.0,"shares_owned_after_display":"2,228,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-09","scope":"insider"},{"id":6338038,"accession":"0001209191-18-058021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-058021","line_url":"/filing/0001209191-18-058021#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7211.0,"shares_display":"7,211","price_per_share":12.0031,"price_display":"12.00","price_state":"stated","total_value":86554.3541,"total_display":"86,554.35","total_whole":"86,554","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-07","filed_date":"2018-11-09","scope":"insider"},{"id":6824964,"accession":"0001209191-18-040520","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-040520","line_url":"/filing/0001209191-18-040520#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.1,"price_display":"14.10","price_state":"stated","total_value":1410.0,"total_display":"1,410.00","total_whole":"1,410","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-29","filed_date":"2018-07-02","scope":"insider"},{"id":6824957,"accession":"0001209191-18-040520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-040520","line_url":"/filing/0001209191-18-040520#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10757.0,"shares_display":"10,757","price_per_share":14.0019,"price_display":"14.00","price_state":"stated","total_value":150618.4383,"total_display":"150,618.44","total_whole":"150,618","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-28","filed_date":"2018-07-02","scope":"insider"},{"id":6760149,"accession":"0001209191-18-032804","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-032804","line_url":"/filing/0001209191-18-032804#line-7","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27928.0,"shares_display":"27,928","price_per_share":13.0082,"price_display":"13.01","price_state":"stated","total_value":363293.0096,"total_display":"363,293.01","total_whole":"363,293","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-23","scope":"insider"},{"id":6760145,"accession":"0001209191-18-032804","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-032804","line_url":"/filing/0001209191-18-032804#line-5","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30932.0,"shares_display":"30,932","price_per_share":13.0011,"price_display":"13.00","price_state":"stated","total_value":402150.0252,"total_display":"402,150.03","total_whole":"402,150","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-22","filed_date":"2018-05-23","scope":"insider"},{"id":6760140,"accession":"0001209191-18-032804","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-032804","line_url":"/filing/0001209191-18-032804","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33938.0,"shares_display":"33,938","price_per_share":12.552940426660381,"price_display":"12.55","price_state":"stated","total_value":426021.6922,"total_display":"426,021.69","total_whole":"426,022","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-21","filed_date":"2018-05-23","scope":"insider","n_lines":2},{"id":6421869,"accession":"0001209191-18-031204","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-031204","line_url":"/filing/0001209191-18-031204#line-6","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17798.0,"shares_display":"17,798","price_per_share":12.1439,"price_display":"12.14","price_state":"stated","total_value":216137.1322,"total_display":"216,137.13","total_whole":"216,137","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-17","scope":"insider"},{"id":6421864,"accession":"0001209191-18-031204","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-031204","line_url":"/filing/0001209191-18-031204#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82202.0,"shares_display":"82,202","price_per_share":12.2584,"price_display":"12.26","price_state":"stated","total_value":1007664.9968,"total_display":"1,007,665.00","total_whole":"1,007,665","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-17","scope":"insider"},{"id":6421859,"accession":"0001209191-18-031204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-031204","line_url":"/filing/0001209191-18-031204#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":11.3206,"price_display":"11.32","price_state":"stated","total_value":1132060.0,"total_display":"1,132,060.00","total_whole":"1,132,060","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-17","scope":"insider"},{"id":6332739,"accession":"0001209191-18-027937","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-027937","line_url":"/filing/0001209191-18-027937#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32873.0,"shares_display":"32,873","price_per_share":11.0258,"price_display":"11.03","price_state":"stated","total_value":362451.1234,"total_display":"362,451.12","total_whole":"362,451","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-02","filed_date":"2018-05-03","scope":"insider"},{"id":6332733,"accession":"0001209191-18-027937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-027937","line_url":"/filing/0001209191-18-027937#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001423084","owner_name":"Schall Thomas J.","owner_display_name":"Schall Thomas J.","owner_url":"/insider/0001423084","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17127.0,"shares_display":"17,127","price_per_share":11.0006,"price_display":"11.00","price_state":"stated","total_value":188407.2762,"total_display":"188,407.28","total_whole":"188,407","shares_owned_after":2184994.0,"shares_owned_after_display":"2,184,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-01","filed_date":"2018-05-03","scope":"insider"}],"collapsed":true,"next_cursor":"2018-05-01|6332733","ledger_fault":false,"count":{"value":104,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":100,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":104},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001790340","name":"Immuneering Corp","url":"/issuer/0001790340","role":"Director","n_filings":4,"first_seen":"2024-03-25","last_seen":"2026-01-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001340652","name":"ChemoCentryx, Inc.","url":"/issuer/0001340652","role":"Director, Officer (President and CEO)","n_filings":42,"first_seen":"2012-10-03","last_seen":"2022-08-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001423084","retrieved_at":"2026-08-23T13:04:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}